MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
20.93%
Quick Ratio
20.57%
Cash Ratio
9.36%
Debt to Asset Ratio
500.92%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other current assets
    • Prepaid expenses
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in-capital
    • Current portion of long-term deb...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
12,841
17,180
36,176
17,435
Restricted cash
960
0
1,144
1,140
Accounts receivable, net
82
216
0
17
Inventory
483
500
459
506
Prepaid expenses
3,074
3,945
5,690
5,150
Other current assets
11,260
12,067
934
995
Total current assets
28,700
33,908
44,403
25,243
Property and equipment, net
99
117
249
324
Operating lease right-of-use assets
0
0
140
222
Other assets
-
-
0
-
Total assets
28,799
34,025
44,792
25,789
Accounts payable
18,783
16,247
16,276
16,692
Accrued expenses
3,921
6,388
4,363
5,090
Current portion of long-term debt
104,451
22,431
16,823
11,216
Other current liabilities-Related Party
157
178
122
122
Other current liabilities-Nonrelated Party
9,837
9,750
220
256
Total current liabilities
137,149
54,994
37,804
33,376
Long-term portion of operating lease liabilities
-
-
0
-
Derivative liabilities
7,110
6,716
3,605
2,611
Long-term debt
0
77,858
92,302
97,469
Total liabilities
144,259
139,568
133,711
133,456
Common stock, 0.001 par value, 200,000 shares authorized as of june 30, 2026 and december 31, 2025 31,305 and 22,328 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
31
27
73
60
Additional paid-in-capital
632,007
627,215
618,557
568,911
Accumulated deficit
-747,498
-732,785
-707,549
-676,638
Total stockholders' (deficit) equity
-115,460
-105,543
-88,919
-107,667
Total liabilities and stockholders' (deficit) equity
28,799
34,025
44,792
25,789
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$12,841K (-26.35%↓ Y/Y)Other current assets$11,260K (1031.66%↑ Y/Y)Prepaid expenses$3,074K (-40.31%↓ Y/Y)Restricted cash$960K (-15.79%↓ Y/Y)Inventory$483K (-4.55%↓ Y/Y)Accounts receivable, net$82K (382.35%↑ Y/Y)Total current assets$28,700K (13.69%↑ Y/Y)Property and equipment,net$99K (-69.44%↓ Y/Y)Total assets$28,799K (11.67%↑ Y/Y)Accumulated deficit-$747,498K (-10.47%↓ Y/Y)Total liabilities andstockholders' (deficit)...$28,799K (11.67%↑ Y/Y)Total stockholders'(deficit) equity-$115,460K (-7.24%↓ Y/Y)Additionalpaid-in-capital$632,007K (11.09%↑ Y/Y)Common stock, 0.001 parvalue, 200,000 shares...$31K (-48.33%↓ Y/Y)Total liabilities$144,259K (8.09%↑ Y/Y)Total currentliabilities$137,149K (310.92%↑ Y/Y)Derivative liabilities$7,110K (172.31%↑ Y/Y)Current portion oflong-term debt$104,451K (1031.27%↑ Y/Y)Accounts payable$18,783K (12.53%↑ Y/Y)Other currentliabilities-Nonrelated Party$9,837K (3742.58%↑ Y/Y)Accrued expenses$3,921K (-22.97%↓ Y/Y)Other currentliabilities-Related Party$157K (28.69%↑ Y/Y)

BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics, Inc. (BTAI)